Francisco Gaytán Luna-rekin lankidetzan egindako argitalpenak (6)

2014

  1. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: Implications for treatment of OHSS with dopamine receptor 2 agonists

    Fertility and Sterility, Vol. 102, Núm. 5, pp. 1468-1476.e1

  2. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: Implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists

    Fertility and Sterility, Vol. 101, Núm. 5

2011

  1. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for OHSS development and treatment

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 8, pp. 2484-2492

  2. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis

    Reproduction, Vol. 142, Núm. 5, pp. 745-755

2009

  1. KiSS-1 in the mammalian ovary: Distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 296, Núm. 3

2006

  1. Expression of KiSS-1 in rat ovary: Putative local regulator of ovulation?

    Endocrinology, Vol. 147, Núm. 10, pp. 4852-4862